Literature DB >> 892898

Bacteriocins as factors in the in vitro interaction between oral streptococci in plaque.

A Weerkamp, L Bongaerts-Larik, G D Vogels.   

Abstract

The effect of bacteriocins on the composition of dental plaque flora was studied in vitro with bacterial plaque formed by oral streptococci on glass rods suspended in broth medium. Cell-free preparations containing mutacin SW31, a bacteriocin produced by Streptococcus mutans, killed sensitive cells present in the plaque selectively, but did not affect resistant cells. Similar preparations from a non-bacteriocinogenic mutant exerted only a slight effect. Mixed growth of bacteriocin-producing S. mutans SW31 with the sensitive S. sanguis Ny101 resulted in a nearly single-strain plaque of the former. Mutacin could be detected in the plaque substance as well as in the surrounding medium. A non-bacteriocinogenic mutant, which was shown not to be altered in functions affecting growth in plaque, allowed substantial growth of S. sanguis Ny101. Sequential inoculation of the bacteriocinogenic plaque former S. sanguis P3A3 and the sensitive S. mutans OMZ61 showed that the cells of the latter are killed rapidly in established plaques when inoculated with the bacteriocinogenic strain. A trypsin-sensitive antagonistic substance could be detected in the plaque, but not in the surrounding medium. The results indicate that bacteriocins can be active in plaque in vitro and suggest that bacteriocins could play a role in determining the composition of plaque in vivo.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892898      PMCID: PMC421029          DOI: 10.1128/iai.16.3.773-780.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Bacteriocin patterns of strains belonging to various serotypes of Streptococcus mutans.

Authors:  A H Rogers
Journal:  Arch Oral Biol       Date:  1976       Impact factor: 2.633

2.  Production and properties of bacteriocins (mutacins) from Streptococcus mutans.

Authors:  S Hamada; T Ooshima
Journal:  Arch Oral Biol       Date:  1975-10       Impact factor: 2.633

3.  Activity of two Streptococcus mutans bacteriocins in the presence of saliva, levan, and dextran.

Authors:  A L Delisle
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

4.  Antagonistic substances produced by streptococci from human dental plaque and their significance in plaque ecology.

Authors:  A Weerkamp; G D Vogels; M Skotnicki
Journal:  Caries Res       Date:  1977       Impact factor: 4.056

Review 5.  The normal microbial flora of the mouth.

Authors:  J M Hardie; G H Bowden
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

6.  The production of L(+) and D(-) lactic acid and volatile acids by human dental plaque and the effect of plaque buffering and acidic strength on pH.

Authors:  D A Geddes
Journal:  Arch Oral Biol       Date:  1972-03       Impact factor: 2.633

7.  Production of bactericidal concentrations of hydrogen peroxide by Streptococcus sanguis.

Authors:  K Holmberg; H O Hallander
Journal:  Arch Oral Biol       Date:  1973-03       Impact factor: 2.633

8.  The distribution of Streptococcus mutans on the teeth of two groups of naval recruits.

Authors:  I L Shklair; H J Keene; P Cullen
Journal:  Arch Oral Biol       Date:  1974-02       Impact factor: 2.633

9.  Bacteriocin production and susceptibility among strains of Streptococcus mutans grown in the presence of sucrose.

Authors:  A H Rogers
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

10.  In vitro attachment of streptococci to the tooth surface.

Authors:  D Orstavik; F W Kraus; L C Henshaw
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more
  12 in total

Review 1.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

2.  The hdrRM operon of Streptococcus mutans encodes a novel regulatory system for coordinated competence development and bacteriocin production.

Authors:  Toshinori Okinaga; Guoqing Niu; Zhoujie Xie; Fengxia Qi; Justin Merritt
Journal:  J Bacteriol       Date:  2010-01-29       Impact factor: 3.490

3.  Identification of a novel bacteriocin regulatory system in Streptococcus mutans.

Authors:  Zhoujie Xie; Toshinori Okinaga; Guoqing Niu; Fengxia Qi; Justin Merritt
Journal:  Mol Microbiol       Date:  2010-11-02       Impact factor: 3.501

4.  Diacylglycerol kinase is involved in regulation of expression of the lantibiotic mutacin II of Streptococcus mutans.

Authors:  P Chen; J Novak; F Qi; P W Caufield
Journal:  J Bacteriol       Date:  1998-01       Impact factor: 3.490

5.  Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii.

Authors:  Bing-Yan Wang; Howard K Kuramitsu
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

6.  Effect of bacteriocin production by Streptococcus mutans on the plaque of gnotobiotic rats.

Authors:  A H Rogers; J S van der Hoeven; F H Mikx
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Isolation of a Streptococcus mutans strain producing a novel bacteriocin.

Authors:  J D Hillman; K P Johnson; B I Yaphe
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

8.  Stability of the resident microflora and the bacteriocinogeny of Streptococcus mutans as factors affecting its establishment in specific pathogen-free rats.

Authors:  J S van der Hoeven; A H Rogers
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Production, purification, and properties of a bacteriocin from Staphylococcus aureus isolated from saliva.

Authors:  T Nakamura; N Yamazaki; H Taniguchi; S Fujimura
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Characterization of the adherence properties of Streptococcus salivarius.

Authors:  A H Weerkamp; B C McBride
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.